|
Volumn 20, Issue 9, 2010, Pages 2761-2764
|
Squalenoyl nucleoside monophosphate nanoassemblies: New prodrug strategy for the delivery of nucleotide analogues
|
Author keywords
Antitumor agents; Antiviral agents; Nanoassemblies; Nucleotides; Prodrug
|
Indexed keywords
4 (N) 1,1', 2 TRISNOR SQUALENOYLDIDEOXYCYTIDINE MONOPHOSPHATE;
4 (N) 1,1',2 TRISNORSQUALENOYLGEMCITABINE MONOPHOSPHATE;
4 (N) TRISNOR SQUALENOYLDIDEOXYCYTIDINE;
4 (N) TRISNOR SQUALENOYLDIDEOXYCYTIDINE MONOPHOSPHATE;
4 (N) TRISNOR SQUALENOYLGEMCITABINE;
4 (N) TRISNOR SQUALENOYLGEMCITABINE MONOPHOSPHATE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
GEMCITABINE;
NANOMATERIAL;
NUCLEOTIDE;
PHOSPHORAMIDOUS ACID DERIVATIVE;
PRODRUG;
SQUALENOYLGEMCITABINE MONOPHOSPHATE;
SQUALENOYLNUCLEOSIDE MONOPHOSPHATE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG SYNTHESIS;
MOUSE;
NONHUMAN;
PARTICLE SIZE;
TRANSMISSION ELECTRON MICROSCOPY;
|
EID: 77950858351
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.03.070 Document Type: Article |
Times cited : (37)
|
References (27)
|